Efficiency of Pulmonary Administration of Tobramycin Solution for Inhalation in Cystic Fibrosis Using an Improved Drug Delivery System

Chest- United States

doi 10.1378/chest.123.1.28

Full Text

Abstract

Available in

Categories

Cardiovascular Medicine

Intensive Care Medicine

Respiratory Medicine

Date

January 1, 2003

Authors

David E. Geller

Margaret Rosenfeld

Robert W. Wilmott

Publisher

Elsevier BV

Related search

Tobramycin Inhalation Powder in Cystic Fibrosis Patients: Response by Age Group

Respiratory Care

Respiratory Medicine

Intensive Care Medicine

English

Home Videos of Cystic Fibrosis Patients Using Tobramycin Inhalation Powder: Relation of Flow and Cough

Pediatric Pulmonology

Respiratory Medicine

English

Safety, Efficacy and Convenience of Tobramycin Inhalation Powder in Cystic Fibrosis Patients: The EAGER Trial

Journal of Cystic Fibrosis

Respiratory Medicine

English

PIN107 Tobramycin Inhaled Solution Utilization by Cystic Fibrosis Patients: An Analysis With the RAMQ Database

Value in Health

Occupational Health

English

Development of Levofloxacin Inhalation Solution to Treat Pseudomonas Aeruginosa in Patients With Cystic Fibrosis

Therapeutic Advances in Respiratory Disease

Respiratory Medicine

English

Bayesian Estimation of Tobramycin Exposure in Patients With Cystic Fibrosis

Antimicrobial Agents and Chemotherapy

Infectious Diseases

English

The Pharmacokinetics and Toxicity of Morning vs. Evening Tobramycin Dosing for Pulmonary Exacerbations of Cystic Fibrosis: A Randomised Comparison

Journal of Cystic Fibrosis

Respiratory Medicine

English

Treatment of Pulmonary Exacerbations of Cystic Fibrosis Leads to Improved Antioxidant Status

European Respiratory Journal

Respiratory Medicine

English

Efficacy, Tolerance, and Pharmacokinetics of Once Daily Tobramycin for Pseudomonas Exacerbations in Cystic Fibrosis

Archives of Disease in Childhood

English